Evidence map›Paper›PMID 20027616›Full record

ArticleGenesis (New York, N.Y. : 2000)2010

Construction of a dual affinity tagged allele of the Rb1 tumor suppressor gene in the mouse.

Hai Xiao, Xiaojing Zhang, David W Goodrich

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Epidemiology and Rb1 gene of retinoblastoma.International journal of ophthalmology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hai XiaoDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Xiaojing Zhang
David W Goodrich
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Requirements for Normal Rb Function In VivoR01CA070292 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI GOODRICH, DAVID W. · 1996 to 2010
$2.9M
The Role of Thoc1 in Normal Development and CancerR01CA125665 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GOODRICH, DAVID W. · 2007 to 2011
$1.8M
NCI NIH HHS CA016056NCI NIH HHS CA70292NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA070292NCI NIH HHS R01 CA125665
6 · The paper itself

Abstract

Loss of Rb1 tumor suppressor gene function is involved in the genesis of most human cancers. Novel therapies targeting Rb1 have been slow to develop because of our incomplete understanding of its molecular mechanisms of action. Rb1 protein (pRb) binds a host of cellular genes and proteins, and these molecular interactions mediate its various functions. Given the potential complexity of these molecular interactions and the lack of established methods for pRb purification, it has been difficult to systematically identify gene and protein interactions relevant to tumor suppression in different tissues in vivo. To address this limitation, we have generated a dual affinity tagged Rb1 allele in the mouse. The tagged allele functions as wild type and the encoded protein can be purified by tandem affinity chromatography. This allele will facilitate identification and characterization of native pRb molecular interactions in any tissue accessible in the mouse.

Indexed as

AllelesGenes, Tumor SuppressorAnimalsChimeraChromatography, AffinityCrosses, GeneticExonsHomozygoteIntronsMiceMice, Inbred C57BLModels, GeneticRetinoblastoma ProteinRetinoblastoma Protein

Identifiers

PMID20027616
PMCPMC2819610
OpenAlexW2086100627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.